5
votes
One of the best drug candidates for Alzheimer's, aducanumab, just failed to demonstrate efficacy
Link information
This data is scraped automatically and may be incorrect.
- Title
- Biogen and Eisai to Discontinue Phase 3 ENGAGE and EMERGE Trials of aducanumab in Alzheimer's Disease | Biogen
- Word count
- 1287 words
More background in another article: https://www.sciencemag.org/news/2019/03/another-major-drug-candidate-targeting-brain-plaques-alzheimer-s-disease-has-failed
Ahh, missed a comma in the title. Can't edit now :-(
After the nonessential appositive? I gotcha. :)
Thanks :)